Skip to main content
SpringerLink
Log in
Book cover

Thyroid and Heart pp 263–277Cite as

Arrhythmias in Thyroid Disorders

  • Chapter
  • First Online:

  • 437 Accesses

Abstract

The most common clinical manifestations of thyrotoxic heart disease are heart rate disorders, in particular sinus tachycardia and atrial fibrillation, which are present in 28% of patients [1]. Typical arrhythmias found in hyperthyroidism are atrial premature contractions or atrial fibrillation, the latter occurring in 9–22% of patients [2]. Conversely, ventricular premature contractions are rare in this setting, and if present, their frequency is not decreased after treatment [3]. Malignant ventricular arrhythmias such as ventricular tachycardia or fibrillation, which are potentially fatal, are exceptional [4] and usually occur only in patients with marked heart failure or associated cardiac disease [5]. Surprisingly, there have been few population-based studies examining the long-term influence of thyroid disease and its treatment on morbidity and mortality [6].

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   69.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   89.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 1994;331(19):1249–52.

    Article  CAS  PubMed  Google Scholar 

  2. Golf S, Løvstad R, Hansson V. Beta-adrenoceptor density and relative number of beta-adrenoceptor subtypes in biopsies from human right atrial, left ventricular, and right ventricular myocard. Cardiovasc Res. 1985;19(10):636–41.

    Article  CAS  PubMed  Google Scholar 

  3. Von Olshausen K, Bischoff S, Kahaly G, Mohr-Kahaly S, Erbel R, Beyer J, et al. Cardiac arrhythmias and heart rate in hyperthyroidism. Am J Cardiol. 1989;63(13):930–3.

    Article  Google Scholar 

  4. Roffi M, Cattaneo F, Brandle M. Thyrotoxicosis and the cardiovascular system. Minerva Endocrinol. 2005;30(2):47–58.

    CAS  PubMed  Google Scholar 

  5. Polikar R, Burger AG, Scherrer U, Nicod P. The thyroid and the heart. Circulation. 1993;87(5):1435–41.

    Article  CAS  PubMed  Google Scholar 

  6. Osman F, Gammage MD, Sheppard MC, Franklyn JA. Clinical review 142: cardiac dysrhythmias and thyroid dysfunction: the hidden menace? J Clin Endocrinol Metab. 2002;87(3):963–7.

    Article  CAS  PubMed  Google Scholar 

  7. Glass CK, Holloway JM. Regulation of gene expression by the thyroid hormone receptor. Biochim Biophys Acta. 1990;1032(2–3):157–76.

    CAS  PubMed  Google Scholar 

  8. Brent GA. The molecular basis of thyroid hormone action. N Engl J Med. 1994;331(13):847–53.

    Article  CAS  PubMed  Google Scholar 

  9. Woeber KA. Thyrotoxicosis and the heart. N Engl J Med. 1992;327(2):94–8.

    Article  CAS  PubMed  Google Scholar 

  10. Dillmann WH. Biochemical basis of thyroid hormone action in the heart. Am J Med. 1990;88(6):626–30.

    Article  CAS  PubMed  Google Scholar 

  11. Klein I, Ojamaa K, Samarel AM, Welikson R, Hong C. Hemodynamic regulation of myosin heavy chain gene expression. Studies in the transplanted rat heart. J Clin Invest. 1992;89(1):68–73.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Danzi S, Klein S, Klein I. Differential regulation of the myosin heavy chain genes alpha and beta in rat atria and ventricles: role of antisense RNA. Thyroid. 2008;18(7):761–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Ojamaa K, Kenessey A, Klein I. Thyroid hormone regulation of phospholamban phosphorylation in the rat heart. Endocrinology. 2000;141(6):2139–44.

    Article  CAS  PubMed  Google Scholar 

  14. Liu B, Huang F, Gick G. Regulation of Na,K-ATPase beta 1 mRNA content by thyroid hormone in neonatal rat cardiac myocytes. Cell Mol Biol Res. 1993;39(3):221–9.

    CAS  PubMed  Google Scholar 

  15. Ojamaa K, Sabet A, Kenessey A, Shenoy R, Klein I. Regulation of rat cardiac Kv1.5 gene expression by thyroid hormone is rapid and chamber specific. Endocrinology. 1999;140(7):3170–6.

    Article  CAS  PubMed  Google Scholar 

  16. Davis PJ, Davis FB, Lin H-Y, Mousa SA, Zhou M, Luidens MK. Translational implications of nongenomic actions of thyroid hormone initiated at its integrin receptor. Am J Physiol Endocrinol Metab. 2009;297(6):E1238–46.

    Article  CAS  PubMed  Google Scholar 

  17. Bonow RO, Mann DL, Zipes DP, Libby P. Braunwald’s heart disease: a textbook of cardiovascular medicine. Elsevier Health Sciences;2011. 11033 p.

    Google Scholar 

  18. Sun ZQ, Ojamaa K, Nakamura TY, Artman M, Klein I, Coetzee WA. Thyroid hormone increases pacemaker activity in rat neonatal atrial myocytes. J Mol Cell Cardiol. 2001;33(4):811–24.

    Article  CAS  PubMed  Google Scholar 

  19. Hagiwara N, Irisawa H, Kasanuki H, Hosoda S. Background current in sino-atrial node cells of the rabbit heart. J Physiol. 1992;448:53–72.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Hagiwara N, Irisawa H, Kameyama M. Contribution of two types of calcium currents to the pacemaker potentials of rabbit sino-atrial node cells. J Physiol. 1988;395:233–53.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Kodama I, Boyett MR, Nikmaram MR, Yamamoto M, Honjo H, Niwa R. Regional differences in effects of E-4031 within the sinoatrial node. Am J Physiol. 1999;276(3 Pt 2):H793–802.

    CAS  PubMed  Google Scholar 

  22. Hüser J, Blatter LA, Lipsius SL. Intracellular Ca2+ release contributes to automaticity in cat atrial pacemaker cells. J Physiol. 2000;524(Pt 2):415–22.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Kiehn J, Karle C, Thomas D, Yao X, Brachmann J, Kübler W. HERG potassium channel activation is shifted by phorbol esters via protein kinase A-dependent pathways. J Biol Chem. 1998;273(39):25285–91.

    Article  CAS  PubMed  Google Scholar 

  24. Johnson PN, Freedberg AS, Marshall JM. Action of thyroid hormone on the transmembrane potentials from sinoatrial node cells and atrial muscle cells in isolated atria of rabbits. Cardiology. 1973;58(5):273–89.

    Article  CAS  PubMed  Google Scholar 

  25. Sakaguchi Y, Cui G, Sen L. Acute effects of thyroid hormone on inward rectifier potassium channel currents in Guinea pig ventricular myocytes. Endocrinology. 1996;137(11):4744–51.

    Article  CAS  PubMed  Google Scholar 

  26. Apkon M, Nerbonne JM. Characterization of two distinct depolarization-activated K+ currents in isolated adult rat ventricular myocytes. J Gen Physiol. 1991;97(5):973–1011.

    Article  CAS  PubMed  Google Scholar 

  27. Sun ZQ, Ojamaa K, Coetzee WA, Artman M, Klein I. Effects of thyroid hormone on action potential and repolarizing currents in rat ventricular myocytes. Am J Physiol Endocrinol Metab. 2000;278(2):E302–7.

    Article  CAS  PubMed  Google Scholar 

  28. Levey GS, Klein I. Catecholamine-thyroid hormone interactions and the cardiovascular manifestations of hyperthyroidism. Am J Med. 1990;88(6):642–6.

    Article  CAS  PubMed  Google Scholar 

  29. Williams LT, Lefkowitz RJ, Watanabe AM, Hathaway DR, Besch HR Jr. Thyroid hormone regulation of beta-adrenergic receptor number. J Biol Chem. 1977;252(8):2787–9.

    CAS  PubMed  Google Scholar 

  30. Morkin E, Flink IL, Goldman S. Biochemical and physiologic effects of thyroid hormone on cardiac performance. Prog Cardiovasc Dis. 1983;25(5):435–64.

    Article  CAS  PubMed  Google Scholar 

  31. Hoit BD, Khoury SF, Shao Y, Gabel M, Liggett SB, Walsh RA. Effects of thyroid hormone on cardiac beta-adrenergic responsiveness in conscious baboons. Circulation. 1997;96(2):592–8.

    Article  CAS  PubMed  Google Scholar 

  32. N J, Francis J. Atrial fibrillation and hyperthyroidism. Indian Pacing Electrophysiol J. 2005;5(4):305–11.

    PubMed  PubMed Central  Google Scholar 

  33. Ojamaa K, Klein I, Sabet A, Steinberg SF. Changes in adenylyl cyclase isoforms as a mechanism for thyroid hormone modulation of cardiac beta-adrenergic receptor responsiveness. Metabolism. 2000;49(2):275–9.

    Article  CAS  PubMed  Google Scholar 

  34. Farre J. Philippe Coumel: a founding father of modern arrhythmology. Europace. 2004;6(5):464–5.

    Article  PubMed  Google Scholar 

  35. Freedberg AS, Papp JG, Williams EM. The effect of altered thyroid state on atrial intracellular potentials. J Physiol. 1970;207(2):357–69.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  36. Chen Y-C, Chen S-A, Chen Y-J, Chang M-S, Chan P, Lin C-I. Effects of thyroid hormone on the arrhythmogenic activity of pulmonary vein cardiomyocytes. J Am Coll Cardiol. 2002;39(2):366–72.

    Article  CAS  PubMed  Google Scholar 

  37. Rubinstein I, Binah O. Thyroid hormone modulates membrane currents in guinea-pig ventricular myocytes. Naunyn Schmiedebergs Arch Pharmacol. 1989;340(6):705–11.

    Article  CAS  PubMed  Google Scholar 

  38. Haïssaguerre M, Jaïs P, Shah DC, Takahashi A, Hocini M, Quiniou G, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339(10):659–66.

    Article  PubMed  Google Scholar 

  39. Chen YJ, Chen SA, Chen YC, Yeh HI, Chan P, Chang MS, et al. Effects of rapid atrial pacing on the arrhythmogenic activity of single cardiomyocytes from pulmonary veins: implication in initiation of atrial fibrillation. Circulation. 2001;104(23):2849–54.

    Article  CAS  PubMed  Google Scholar 

  40. Komiya N, Isomoto S, Nakao K, Hayano M, Yano K. Electrophysiological abnormalities of the atrial muscle in patients with paroxysmal atrial fibrillation associated with hyperthyroidism. Clin Endocrinol (Oxf). 2002;56(1):39–44.

    Article  Google Scholar 

  41. Jao YTFN, Chen Y, Lee W-H, Tai F-T. Thyroid storm and ventricular tachycardia. South Med J. 2004;97(6):604–7.

    Article  PubMed  Google Scholar 

  42. Boccalandro C, López-Penabad L, Boccalandro F, Lavis V. Ventricular fibrillation in a young Asian man. Lancet. 2003;361(9367):1432.

    Article  PubMed  Google Scholar 

  43. Fisher J. Thyrotoxic periodic paralysis with ventricular fibrillation. Arch Intern Med. 1982;142(7):1362–4.

    Article  CAS  PubMed  Google Scholar 

  44. Muñoz-Camacho JF, Sagristá-Sauleda J. Malignant ventricular arrhythmias as the initial manifestation of hyperthyroidism. Rev Esp Cardiol Engl Ed. 2007;60(4):449–50.

    Article  Google Scholar 

  45. Wei JY, Genecin A, Greene HL, Achuff SC. Coronary spasm with ventricular fibrillation during thyrotoxicosis: response to attaining euthyroid state. Am J Cardiol. 1979;43(2):335–9.

    Article  CAS  PubMed  Google Scholar 

  46. Biondi B, Fazio S, Coltorti F, Palmieri EA, Carella C, Lombardi G, et al. Clinical case seminar: reentrant atrioventricular nodal tachycardia induced by levothyroxine. J Clin Endocrinol Metab. 1998;83(8):2643–5.

    Article  CAS  PubMed  Google Scholar 

  47. Gross G, Lues I. Thyroid-dependent alterations of myocardial adrenoceptors and adrenoceptor-mediated responses in the rat. Naunyn Schmiedebergs Arch Pharmacol. 1985;329(4):427–39.

    Article  CAS  PubMed  Google Scholar 

  48. Jaeger JM, Houser SR, Freeman AR, Spann JF Jr. Effect of thyroid hormone on canine cardiac Purkinje fiber transmembrane potential. Am J Physiol. 1981;240(6):H934–40.

    CAS  PubMed  Google Scholar 

  49. Qu Z, Weiss JN. Dynamics and cardiac arrhythmias. J Cardiovasc Electrophysiol. 2006;17(9):1042–9.

    Article  PubMed  Google Scholar 

  50. Meo SD, de Martino Rosaroll P, Piro MC, De Leo T. Electrophysiological properties of the hyperthyroid rat heart. Arch Int Physiol Biochim Biophys. 1994;102(2):153–9.

    CAS  PubMed  Google Scholar 

  51. Buscemi S, Verga S, Cottone S, Andronico G, D’Orio L, Mannino V, et al. Favorable clinical heart and bone effects of anti-thyroid drug therapy in endogenous subclinical hyperthyroidism. J Endocrinol Invest. 2007;30(3):230–5.

    Article  CAS  PubMed  Google Scholar 

  52. Polikar R, Goy JJ, Schlapfer J, Lemarchand-Beraud T, Biollaz J, Magnenat P, et al. Effect of oral triiodothyronine during amiodarone treatment for ventricular premature complexes. Am J Cardiol. 1986;58(10):987–91.

    Article  CAS  PubMed  Google Scholar 

  53. Tribulova N, Knezl V, Shainberg A, Seki S, Soukup T. Thyroid hormones and cardiac arrhythmias. Vascul Pharmacol. 2010;52(3–4):102–12.

    Article  CAS  PubMed  Google Scholar 

  54. Surawicz B, Mangiardi ML. Electrocardiogram in endocrine and metabolic disorders. Cardiovasc Clin. 1977;8(3):243–66.

    CAS  PubMed  Google Scholar 

  55. Nademanee K, Singh BN, Hendrickson JA, Reed AW, Melmed S, Hershman J. Pharmacokinetic significance of serum reverse T3 levels during amiodarone treatment: a potential method for monitoring chronic drug therapy. Circulation. 1982;66(1):202–11.

    Article  CAS  PubMed  Google Scholar 

  56. Polikar R, Feld GK, Dittrich HC, Smith J, Nicod P. Effect of thyroid replacement therapy on the frequency of benign atrial and ventricular arrhythmias. J Am Coll Cardiol. 1989;14(4):999–1002.

    Article  CAS  PubMed  Google Scholar 

  57. Di Meo S, Venditti P, De Leo T. Effect of iodothyronines on electrophysiological properties of rat papillary muscle fibres. Horm Metab Res. 1997;29(5):225–30.

    Article  PubMed  Google Scholar 

  58. Schenck JB, Rizvi AA, Lin T. Severe primary hypothyroidism manifesting with torsades de pointes. Am J Med Sci. 2006;331(3):154–6.

    Article  PubMed  Google Scholar 

  59. Fredlund BO, Olsson SB. Long QT interval and ventricular tachycardia of “torsade de pointe” type in hypothyroidism. Acta Med Scand. 1983;213(3):231–5.

    Article  CAS  PubMed  Google Scholar 

  60. Unal O, Erturk E, Ozkan H, Kiyici S, Guclu M, Ersoy C, et al. Effect of levothyroxine treatment on QT dispersion in patients with subclinical hypothyroidism. Endocr Pract. 2007;13(7):711–5.

    Article  PubMed  Google Scholar 

  61. Lee JK, Lewis JA. Myxoedema with complete A-V block and Adams-Stokes disease abolished with thyroid medication. Br Heart J. 1962;24:253–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Chess-Williams R, Coker SJ. Ventricular fibrillation is reduced in hypothyroid rats with enhanced myocardial alpha-adrenoceptor responsiveness. Br J Pharmacol. 1989;98(1):95–100.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  63. Friberg L, Werner S, Eggertsen G, Ahnve S. Rapid down-regulation of thyroid hormones in acute myocardial infarction: is it cardioprotective in patients with angina? Arch Intern Med. 2002;162(12):1388–94.

    Article  CAS  PubMed  Google Scholar 

  64. Epstein FH, Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001;344(7):501–9.

    Article  Google Scholar 

  65. Frost L, Vestergaard P, Mosekilde L. Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study. Arch Intern Med. 2004;164(15):1675–8.

    Article  PubMed  Google Scholar 

  66. Frost L, Vestergaard P. Alcohol and risk of atrial fibrillation or flutter: a cohort study. Arch Intern Med. 2004;164(18):1993–8.

    Article  PubMed  Google Scholar 

  67. Frost L, Vestergaard P, Mosekilde L, Mortensen LS. Trends in incidence and mortality in the hospital diagnosis of atrial fibrillation or flutter in Denmark, 1980–1999. Int J Cardiol. 2005;103(1):78–84.

    Article  PubMed  Google Scholar 

  68. Tunbridge WM, Evered DC, Hall R, Appleton D, Brewis M, Clark F, et al. The spectrum of thyroid disease in a community: the Whickham survey. Clin Endocrinol (Oxf). 1977;7(6):481–93.

    Article  CAS  Google Scholar 

  69. Klein I, Danzi S. Thyroid disease and the heart. Circulation. 2007;116(15):1725–35.

    Article  PubMed  Google Scholar 

  70. Nakazawa H, Lythall DA, Noh J, Ishikawa N, Sugino K, Ito K, et al. Is there a place for the late cardioversion of atrial fibrillation? A long-term follow-up study of patients with post-thyrotoxic atrial fibrillation. Eur Heart J. 2000;21(4):327–33.

    Article  CAS  PubMed  Google Scholar 

  71. Zhou Z-H, Ma L-L, Wang L-X. Risk factors for persistent atrial fibrillation following successful hyperthyroidism treatment with radioiodine therapy. Intern Med Tokyo Jpn. 2011;50(24):2947–51.

    Article  CAS  Google Scholar 

  72. Xiao P, Gao C, Fan J, Du H, Long Y, Yin Y. Blockade of angiotensin II improves hyperthyroid induced abnormal atrial electrophysiological properties. Regul Pept. 2011;169(1–3):31–8.

    Article  CAS  PubMed  Google Scholar 

  73. Shimizu T, Koide S, Noh JY, Sugino K, Ito K, Nakazawa H. Hyperthyroidism and the management of atrial fibrillation. Thyroid. 2002;12(6):489–93.

    Article  PubMed  Google Scholar 

  74. Kunii Y, Uruno T, Matsumoto M, Mukasa K, Noh J, Ito K, et al. Pharmacological conversion of atrial fibrillation in the patients of Graves’ disease. Tokai J Exp Clin Med. 2012;37(4):107–12.

    CAS  PubMed  Google Scholar 

  75. Bagchi N, Brown TR, Parish RF. Thyroid dysfunction in adults over age 55 years. A study in an urban US community. Arch Intern Med. 1990;150(4):785–7.

    Article  CAS  PubMed  Google Scholar 

  76. Sawin CT, Geller A, Wolf PA, Belanger AJ, Baker E, Bacharach P, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med. 1994;331:1249–52.

    Article  CAS  PubMed  Google Scholar 

  77. Auer J, Scheibner P, Mische T, Langsteger W, Eber O, Eber B. Subclinical hyperthyroidism as a risk factor for atrial fibrillation. Am Heart J. 2001;142:838–42.

    Article  CAS  PubMed  Google Scholar 

  78. Heeringa J, Hoogendoorn EH, Vander Deure WM, Hofman A, Peeters RP, Hop WC, et al. High-normal thyroid function and risk of atrial fibrillation: the Rotterdam study. Arch Intern Med. 2008;168:2219–24.

    Article  PubMed  Google Scholar 

  79. Gammage MD, Parle JV, Holder RL, Roberts LM, Hobbs FD, Wilson S, et al. Association between serum free thyroxine concentration and atrial fibrillation. Arch Intern Med. 2007;167:928–34.

    Article  CAS  PubMed  Google Scholar 

  80. Ozturk S, Dikbas O, Baltacı D, Ozyasar M, Erdem A, Ayhan SS, et al. Evaluation of atrial conduction abnormalities and left atrial mechanical functions in patients with subclinical thyroid disorders. Endokrynol Pol. 2012;63(4):286–93.

    PubMed  Google Scholar 

  81. Gen R, Akbay E, Camsari A, Ozcan T. P-wave dispersion in endogenous and exogenous subclinical hyperthyroidism. J Endocrinol Investig. 2010;33:88–91.

    Article  CAS  Google Scholar 

  82. Cetinarslan B, Akkoyun M, Canturk Z, Tarkun I, Kahranman G, Komsuoglu B. Duration of the P wave and P wave dispersion in subclinical hyperthyroidism. Endocr Pract. 2003;9:200–3.

    Article  PubMed  Google Scholar 

  83. Aras D, Maden O, Ozdemir O, Aras S, Topaloglu S, Yetkin E, et al. Simple electrocardiographic markers for the prediction of paroxysmal atrial fibrillation in hyperthyroidism. Int J Cardiol. 2005;99:59–64.

    Article  PubMed  Google Scholar 

  84. Sgarbi JA, Villaca FG, Garbeline B, Villar HE, Romaldini JH. The effects of early antithyroid therapy for endogenous subclinical hyperthyroidism in clinical and heart abnormalities. J Clin Endocrinol Metab. 2003;88:1672–7.

    Article  CAS  PubMed  Google Scholar 

  85. Biondi B, Fazio S, Palmieri EA, Tremalaterra R, Angellotti G, Bone F, et al. Effects of chronic subclinical hyperthyroidism from levothyroxine on cardiac morphology and function. Cardiologia. 1999;44:443–9.

    CAS  PubMed  Google Scholar 

  86. Sawin CT. Subclinical hypothyroidism in older persons. Clin Geriatr Med. 1995;11(2):231–8.

    Article  CAS  PubMed  Google Scholar 

  87. Klemperer JD, Klein IL, Ojamaa K, Helm RE, Gomez M, Isom OW, et al. Triiodothyronine therapy lowers the incidence of atrial fibrillation after cardiac operations. Ann Thorac Surg. 1996;61(5):1323–7; discussion 1328–9.

    Article  CAS  PubMed  Google Scholar 

  88. Kim E-J, Lyass A, Wang N, Massaro JM, Fox CS, Benjamin EJ, et al. Relation of hypothyroidism and incident atrial fibrillation (from the Framingham Heart Study). Am Heart J. 2014;167(1):123–6.

    Article  PubMed  Google Scholar 

  89. Cappola AR, Arnold AM, Wulczyn K, Carlson M, Robbins J, Psaty BM. Thyroid function in the euthyroid range and adverse outcomes in older adults. J Clin Endocrinol Metab. 2015;100(3):1088–96.

    Article  CAS  PubMed  Google Scholar 

  90. Baumgartner C, da Costa BR, Collet TH, Feller M, Floriani C, Bauer DC, et al. Thyroid function within the normal range, subclinical hypothyroidism, and the risk of atrial fibrillation. Circulation. 2017;136(22):2100–16.

    Article  PubMed  PubMed Central  Google Scholar 

  91. Petersen P, Hansen JM. Stroke in thyrotoxicosis with atrial fibrillation. Stroke J Cereb Circ. 1988;19(1):15–8.

    Article  CAS  Google Scholar 

  92. Siu CW, Pong V, Zhang X, Chan YH, Jim MH, Liu S, et al. Risk of ischemic stroke after new-onset atrial fibrillation in patients with hyperthyroidism. Heart Rhythm. 2009;6(2):169–73.

    Article  PubMed  Google Scholar 

  93. de Souza MV, Dos Santos Teixeira PF, Vaisman M, Salles Xavier S. Is CHA2DS2-VASc appropriate for hyperthyroid patients with atrial fibrillation? Implications of adding a transesophageal echocardiography evaluation. Int J Cardiol. 2017;228:919–25.

    Article  PubMed  Google Scholar 

  94. Chan PH, Hai J, Yeung CY, Lip GY, Lam KS, Tse HF, Siu CW. Benefit of anticoagulation therapy in hyperthyroidism-related atrial fibrillation. Clin Cardiol. 2015;38(8):476–82.

    Article  PubMed  PubMed Central  Google Scholar 

  95. Howard-Thompson A, Luckey A, George C, Choby BA, Self TH. Case report: Graves’ disease and treatment effects on warfarin anticoagulation. Case Rep Med. 2014, Article ID 292468, 6 pages.

    Google Scholar 

  96. Polmear JL, Hare MJ, Catford SR, Topliss DJ, Dooley MJ. Use of anticoagulation in thyroid disease. Aust Fam Physician. 2016;45(3):109–11.

    PubMed  Google Scholar 

  97. Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37:2893–962.

    Article  PubMed  Google Scholar 

  98. Badawi O. Possible effect of thyroid function on anticoagulant response to unfractionated heparin. Pharmacotherapy. 2006;26(2):285–8.

    Article  PubMed  Google Scholar 

  99. Nakazawa HK, Sakurai K, Hamada N, Momotani N, Ito K. Management of atrial fibrillation in the post-thyrotoxic state. Am J Med. 1982;72(6):903–6.

    Article  CAS  PubMed  Google Scholar 

  100. Singh BN. Amiodarone as paradigm for developing new drugs for atrial fibrillation. J Cardiovasc Pharmacol. 2008;52(4):300–5.

    Article  CAS  PubMed  Google Scholar 

  101. Narayana SK, Woods DR, Boos CJ. Management of amiodarone-related thyroid problems. Ther Adv Endocrinol Metab. 2011;2(3):115–26.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  102. Bogazzi F, Tomisti L, Bartalena L, Aghini-Lombardi F, Martino E. Amiodarone and the thyroid: a 2012 update. J Endocrinol Invest. 2012;35(3):340–8.

    CAS  PubMed  Google Scholar 

  103. Cohen-Lehman J, Dahl P, Danzi S, Klein I. Effects of amiodarone therapy on thyroid function. Nat Rev Endocrinol. 2010;6(1):34–41.

    Article  CAS  PubMed  Google Scholar 

  104. Ganz LI, Friedman PL. Supraventricular tachycardia. N Engl J Med. 1995;332(3):162–73.

    Article  CAS  PubMed  Google Scholar 

  105. Denes P, Wu D, Dhingra RC, Chuquimia R, Rosen KM. Demonstration of dual A-V nodal pathways in patients with paroxysmal supraventricular tachycardia. Circulation. 1973;48(3):549–55.

    Article  CAS  PubMed  Google Scholar 

  106. Rosen KM, Mehta A, Miller RA. Demonstration of dual atrioventricular nodal pathways in man. Am J Cardiol. 1974;33(2):291–4.

    Article  CAS  PubMed  Google Scholar 

  107. Abbasoğlu A, Ecevit A, Tuğcu AU, Erdoğan L, Kınık ST, Tarcan A. Neonatal thyrotoxicosis with severe supraventricular tachycardia: case report and review of the literature. J Pediatr Endocrinol Metab. 2015;28(3–4):463–6.

    PubMed  Google Scholar 

  108. Lynch MJ, Woodford NWF. Sudden unexpected death in the setting of undiagnosed Graves’ disease. Forensic Sci Med Pathol. 2014;10(3):452–6.

    Article  PubMed  Google Scholar 

  109. Colzani RM, Emdin M, Conforti F, Passino C, Scarlattini M, Iervasi G. Hyperthyroidism is associated with lengthening of ventricular repolarization. Clin Endocrinol (Oxf). 2001;55(1):27–32.

    Article  CAS  Google Scholar 

  110. Davison ET, Davison MJ. Triiodothyronine (T3) toxicosis with hypokalemic periodic paralysis and ventricular tachycardia. J Electrocardiol. 1995;28(2):161–4.

    Article  CAS  PubMed  Google Scholar 

  111. Dorian P, Cass D. An overview of the management of electrical storm. Can J Cardiol. 1997;13(Suppl A):13A–7A.

    PubMed  Google Scholar 

  112. Erdogan HI, Gul EE, Gok H, Nikus KC. Therapy-resistant ventricular tachycardia caused by amiodarone-induced thyrotoxicosis: a case report of electrical storm. Am J Emerg Med. 2012;30(9):2092.e5–7.

    Article  Google Scholar 

  113. Biondi B, Palmieri EA, Klain M, Schlumberger M, Filetti S, Lombardi G. Subclinical hyperthyroidism: clinical features and treatment options. Eur J Endocrinol Eur Fed Endocr Soc. 2005;152(1):1–9.

    Article  CAS  Google Scholar 

  114. Kaminski G, Makowski K, Michałkiewicz D, Kowal J, Ruchala M, Szczepanek E, Gielerak G. The influence of subclinical hyperthyroidism on blood pressure, heart rate variability, and prevalence of arrhythmias. Thyroid. 2012;22(5):454–60.

    Article  CAS  PubMed  Google Scholar 

  115. Chojnowski K, Bielec A, Czarkowski M, Dmowska-Chalaba J, Kochanowski J, Wasowska A. Repeated ventricular. Cardiol J. 2007;14(2):198–201.

    PubMed  Google Scholar 

  116. Samuels MH. Subclinical thyroid disease in the elderly. Thyroid. 1998;8(9):803–13.

    Article  CAS  PubMed  Google Scholar 

  117. Bakiner O, Ertorer ME, Haydardedeoglu FE, Bozkirli E, Tutuncu NB, Demirag NG. Subclinical hypothyroidism is characterized by increased QT interval dispersion among women. Med Princ Pract. 2008;17(5):390–4.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Cardiology Department, Abderrahman Mami Hospital, Ariana, Tunisia

    Sonia Marrakchi Meziou, Emna Bennour, Ikram Kammoun & Salem Kachboura

  2. Endocrinology Department, La Rabta Hospital, Tunis, Tunisia

    Faouzi Kanoun

  3. University Manar 2 of Tunis, Tunis, Tunisia

    Dania Idriss Marrakchi

Authors
  1. Sonia Marrakchi Meziou
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Emna Bennour
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Faouzi Kanoun
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Dania Idriss Marrakchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ikram Kammoun
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Salem Kachboura
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institute of Clinical Physiology (IFC) National Research Council (CNR), Pisa, Italy

    Giorgio Iervasi

  2. Institute of Clinical Physiology (IFC) National Research Council (CNR), Pisa, Italy

    Alessandro Pingitore

  3. NYITCOM College of Osteopathic Medicine Biomedical Sciences Department, Old Westbury, NY, USA

    A.Martin Gerdes

  4. Institute of Clinical and Translational Medicine, Newcastle University/Queen Elizabeth Hospital, Newcastle upon Tyne, UK

    Salman Razvi

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Marrakchi Meziou, S., Bennour, E., Kanoun, F., Idriss Marrakchi, D., Kammoun, I., Kachboura, S. (2020). Arrhythmias in Thyroid Disorders. In: Iervasi, G., Pingitore, A., Gerdes, A., Razvi, S. (eds) Thyroid and Heart . Springer, Cham. https://doi.org/10.1007/978-3-030-36871-5_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-36871-5_20

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-36870-8

  • Online ISBN: 978-3-030-36871-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation